Davey M Smith Selected Research

Davey M Smith Research Topics

Disease

46	COVID-19 04/2024 - 01/2020
38	Infections 10/2023 - 01/2005
26	HIV Infections (HIV Infection) 02/2024 - 12/2005
11	Viremia 02/2024 - 01/2005
9	Superinfection 06/2023 - 05/2003
6	Inflammation (Inflammations) 01/2023 - 07/2014
6	Neurocognitive Disorders (Clerambault Syndrome) 12/2016 - 04/2012
5	Coinfection 01/2018 - 08/2005
4	Virus Diseases (Viral Diseases) 04/2024 - 01/2015
4	Acquired Immunodeficiency Syndrome (AIDS) 02/2024 - 04/2008
3	Substance-Related Disorders (Drug Abuse) 12/2013 - 11/2009
2	Communicable Diseases (Infectious Diseases) 01/2024 - 01/2023
2	Neoplasms (Cancer) 01/2023 - 10/2019
2	Coronavirus Infections 01/2021 - 09/2020
2	Malaria 09/2012 - 11/2009
1	Critical Illness (Critically Ill) 11/2023
1	Severe Acute Respiratory Syndrome 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	COVID-19 rebound 05/2022
1	Breakthrough Infections 01/2022
1	Pulmonary Edema 12/2021
1	Cytokine Release Syndrome 06/2021
1	Bacterial Infections (Bacterial Infection) 10/2017
1	Pancreatitis 10/2017
1	Pancreatic Pseudocyst 10/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017

Drug/Important Bio-Agent (IBA)

23	RNA (Ribonucleic Acid)IBA 10/2023 - 04/2008
13	VaccinesIBA 01/2024 - 01/2005
12	Monoclonal AntibodiesIBA 04/2024 - 11/2021
12	Antiviral Agents (Antivirals)IBA 03/2023 - 07/2016
8	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 11/2009
8	bamlanivimabIBA 11/2023 - 09/2021
8	Nucleic AcidsIBA 12/2021 - 02/2010
7	EpitopesIBA 11/2023 - 01/2005
7	Neutralizing AntibodiesIBA 10/2023 - 12/2005
6	COVID-19 VaccinesIBA 01/2024 - 01/2021
5	nirmatrelvir and ritonavir drug combinationIBA 04/2023 - 05/2022
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2020
5	AntigensIBA 12/2021 - 06/2012
5	Methamphetamine (Desoxyn)FDA LinkGeneric 03/2016 - 01/2007
4	Messenger RNA (mRNA)IBA 11/2023 - 01/2016
4	Broadly Neutralizing AntibodiesIBA 06/2023 - 01/2022
4	Immunoglobulin G (IgG)IBA 01/2023 - 12/2016
3	AntibodiesIBA 01/2018 - 06/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2023 - 01/2021
2	Ramipril (Altace)FDA LinkGeneric 11/2023 - 01/2021
2	Viral RNAIBA 10/2023 - 08/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 04/2023 - 01/2023
2	CytokinesIBA 01/2023 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2016
2	BNT162 VaccineIBA 03/2021 - 01/2021
2	Emtricitabine (Emtriva)FDA Link 01/2020 - 07/2016
2	Tenofovir (Viread)FDA Link 01/2020 - 07/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2017 - 01/2017
2	Mitochondrial DNA (mtDNA)IBA 04/2016 - 03/2016
2	Codon (Codons)IBA 02/2014 - 05/2009
2	N-acetyltalosaminuronic acid (NAT)IBA 06/2012 - 06/2010
2	Reverse Transcriptase InhibitorsIBA 04/2008 - 01/2007
2	NucleosidesIBA 04/2008 - 01/2007
1	Immunologic Factors (Immunomodulators)IBA 02/2024
1	ogalvibartIBA 01/2024
1	crexavibartIBA 01/2024
1	Therapeutic UsesIBA 11/2023
1	camostatIBA 10/2023
1	Surface-Active Agents (Surfactants)IBA 01/2023
1	InterferonsIBA 01/2023
1	ChemokinesIBA 01/2023
1	IgA receptor (protein B)IBA 01/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2023
1	SAB-185IBA 01/2023
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	PlacebosIBA 01/2023
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2023
1	mRNA VaccinesIBA 01/2022
1	Lipid NanoparticlesIBA 12/2021
1	Interleukin-15 (Interleukin 15)IBA 06/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	RacivirIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 10/2019
1	Maraviroc FDA Link 01/2018
1	HLA-DRB1*07 antigenIBA 01/2017
1	LactamsIBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	HLA-B Antigens (HLA-B)IBA 01/2017
1	HLA-C Antigens (HLA-C)IBA 01/2017

Therapy/Procedure

36	Therapeutics 04/2024 - 05/2003
17	Art Therapy 02/2024 - 01/2013
2	Aftercare (After-Treatment) 02/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 10/2019 - 01/2005
2	Highly Active Antiretroviral Therapy (HAART) 11/2016 - 06/2014
1	Intravenous Administration 01/2024
1	Immunotherapy 01/2023
1	Investigational Therapies (Experimental Therapy) 11/2022
1	Intranasal Administration 12/2021
1	Transjugular Intrahepatic Portasystemic Shunt 12/2021
1	Mechanical Ventilators (Ventilator) 01/2021